Details
| Stereochemistry | UNKNOWN |
| Molecular Formula | C10H7Cl2N3O2 |
| Molecular Weight | 272.087 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1N2CC3=C(Cl)C(Cl)=CC=C3NC2=NC1=O
InChI
InChIKey=KAXTUTDKZVOONF-UHFFFAOYSA-N
InChI=1S/C10H7Cl2N3O2/c11-5-1-2-6-4(7(5)12)3-15-9(17)8(16)14-10(15)13-6/h1-2,9,17H,3H2,(H,13,14,16)
| Molecular Formula | C10H7Cl2N3O2 |
| Molecular Weight | 272.087 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 01:46:17 GMT 2025
by
admin
on
Wed Apr 02 01:46:17 GMT 2025
|
| Record UNII |
PIN0NPZ24B
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135424310
Created by
admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025
|
PRIMARY | |||
|
DTXSID10468915
Created by
admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025
|
PRIMARY | |||
|
PIN0NPZ24B
Created by
admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025
|
PRIMARY | |||
|
733043-41-9
Created by
admin on Wed Apr 02 01:46:17 GMT 2025 , Edited by admin on Wed Apr 02 01:46:17 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
May be responsible for Cardiac related adverse events.
IC50
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE ACTIVE |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Volume of Distribution | PHARMACOKINETIC |
|
|
|||
| Biological Half-life | PHARMACOKINETIC |
|
|
|||